We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 84

Government seeks feedback on new drug safety initiatives
  • Stikeman Elliott LLP
  • Canada
  • May 6 2015

As previously reported, the Food and Drugs Act (the Act) has been substantively amended by Bill C-17, also known as Vanessa's Law; the Bill received


Competition Bureau sets out preliminary views on patent agreement settlement enforcement
  • Stikeman Elliott LLP
  • Canada
  • October 27 2014

On September 23, 2014, John Pecman, the Commissioner of Competition, delivered the keynote address at the George Mason University Pharma Conference


Health and environmental claims an ongoing bureau focus
  • Stikeman Elliott LLP
  • Canada
  • December 18 2007

Investigations and enforcement actions over marketing and advertising claims related to health products and services have been a significant part of the Bureau's recent fair-business-practices work


British Columbia Court of Appeal decertifies pharmaceutical class action
  • Stikeman Elliott LLP
  • Canada
  • March 13 2014

In Wakelam v. Wyeth Consumer Healthcare Wyeth Soins de Sante Inc., 2014 BCCA 36, the British Columbia Court of Appeal overruled a decision


Court of Appeal for Ontario clarifies the duty of care test for cases of regulatory negligence
  • Stikeman Elliott LLP
  • Canada
  • July 17 2012

In the recent decision in Taylor v. Canada (Attorney General), the Court of Appeal for Ontario addressed the requirements for a plaintiff to establish sufficient proximity between the plaintiff and the defendant in a claim brought against a governmental body for regulatory negligence


Bill C-17 (Vanessa’s Law) receives Royal Assent
  • Stikeman Elliott LLP
  • Canada
  • November 11 2014

Bill C-17, An Act to Amend the Foods and Drugs Act (Vanessa's Law) has received Royal Assent and will come into force on a date to be fixed by


Supreme Court issues clear warning of need to respect the "patent bargain"
  • Stikeman Elliott LLP
  • Canada
  • November 12 2012

On Thursday, November 8, 2012, a unanimous Supreme Court of Canada issued a decision with significant implications for those wishing to obtain or enforce Canadian patent rights


Bill C-17 (Vanessa’s Law) receives third reading
  • Stikeman Elliott LLP
  • Canada
  • October 24 2014

Bill C-17, An Act to Amend the Foods and Drugs Act (Vanessa's Law) has proceeded through the committee process without amendment and was read for a


B.C. Court dismisses proposed class action against generic manufacturers of fentanyl patch
  • Stikeman Elliott LLP
  • Canada
  • July 8 2014

On June 20, 2014, Justice Bracken of the British Columbia Supreme Court dismissed a proposed class action against two generic manufacturers of


Senate Committee releases final report on Prescription Pharmaceuticals in Canada
  • Stikeman Elliott LLP
  • Canada
  • March 30 2015

On March 10, 2015, the Standing Senate Committee on Social Affairs, Science and Technology (the Committee) released a final report entitled